| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/25/2002 | US20020048755 Screening drugs for health efficiency; obtain drug, expose to diagnostic testing, expose to humans, monitor activity in humans, monitor health of humans |
| 04/25/2002 | US20020048751 Microarray for use in the detection of preferential particles in sample |
| 04/25/2002 | US20020048747 Method and apparatus for laser microdissection |
| 04/25/2002 | US20020048746 Model for alzheimer's disease and other neurodegenerative diseases |
| 04/25/2002 | US20020048610 High-throughput formation, identification, and analysis of diverse solid-forms |
| 04/25/2002 | US20020048585 Decreasing syndecan-4 expression, level, or activity |
| 04/25/2002 | US20020048581 Modulating Protein Kinase C beta; useful in the treatment of insulin-related disorders, e.g., hypertension. |
| 04/25/2002 | US20020048562 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| 04/25/2002 | US20020048534 Sample preparing arrangement and a method relating to such an arrangement |
| 04/25/2002 | US20020048532 Disposable electrode for whole blood hemoglobin (HGB) and hematocrit (HCT) measurement, and preparation and application thereof |
| 04/25/2002 | US20020048531 Deposited thin films and their use in detection, attachment, and bio-medical applications |
| 04/25/2002 | US20020048306 Method of evaluating the glass-transition temperature of a polymer part during use |
| 04/25/2002 | US20020048021 Method to evaluate the quality of grapes and relative device |
| 04/25/2002 | DE10052832A1 Laboratory assembly treating cytological or histological preparations has series of identical treatment stations for use as required |
| 04/25/2002 | DE10051806A1 Characterization of microbial mixtures, useful e.g. for quality control, comprises comparing spectra and chromatograms with reference data |
| 04/25/2002 | DE10050338A1 Diagnosing and staging of cancer, especially of breast, by measuring levels of insulin receptor substrate-1 or insulin-like growth factor-1 receptor beta |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2463678A1 Assay for directly detecting a rs virus related biological cell in a body fluid sample |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426454A1 Apparatus and method for monitoring characteristics of pharmaceutical compositions during preparation in a fluidized bed |
| 04/25/2002 | CA2426403A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2426249A1 Glucose measurement utilizing non-invasive assessment methods |
| 04/25/2002 | CA2426126A1 A urine test for the diagnosis of prion diseases |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425961A1 Improved ligand binding assays for vanilloid receptors |
| 04/25/2002 | CA2425807A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 04/25/2002 | CA2425763A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | CA2425742A1 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | CA2425723A1 Neuromedin u delta |
| 04/25/2002 | CA2425669A1 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | CA2425362A1 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 04/25/2002 | CA2425174A1 Human gene critical to fertility |
| 04/25/2002 | CA2424764A1 Pattern recognition method for diagnosis of systemic autoimmune diseases |
| 04/25/2002 | CA2424643A1 Cd38 modulated chemotaxis |
| 04/25/2002 | CA2424562A1 New nmr screening method |
| 04/25/2002 | CA2423819A1 Methods for quantitative and qualitative analyses of phospholipids using one-dimensional thin layer chromatography |
| 04/25/2002 | CA2423672A1 Method of operating a computer system to perform a discrete substructural analysis |
| 04/25/2002 | CA2423596A1 Assays |
| 04/25/2002 | CA2423235A1 Method and apparatus for analyzing mixtures of gases |
| 04/25/2002 | CA2405770A1 Shelf life testing unit |
| 04/24/2002 | EP1199751A2 Chip arrangement |
| 04/24/2002 | EP1199669A2 Method and system for designing proteins |
| 04/24/2002 | EP1199568A2 Carbohydrate-deficient transferrin assay |
| 04/24/2002 | EP1199567A1 E. coli agglutination assay |
| 04/24/2002 | EP1199565A1 Diagnostics and remedies for diseases with participation of macrocytes/macrophages |
| 04/24/2002 | EP1199564A2 A method for screening substances for effect on intracellular translocation |
| 04/24/2002 | EP1199562A1 Method for measuring concentrations and molecular weights of glue and gelatin |
| 04/24/2002 | EP1199561A1 Hydrocarbon sensor and method for producing the same |
| 04/24/2002 | EP1199560A1 Electrochemical measuring cell for the determination of the cell count and the biological activity |
| 04/24/2002 | EP1199554A2 Analytical method and apparatus for blood using near infrared spectroscopy |
| 04/24/2002 | EP1199371A2 Methods for identifying products employing reporter gene expression |
| 04/24/2002 | EP1199370A1 Process for detecting dephosphorylation of phosphorylated threonine or serine by phosphatase activity |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds |
| 04/24/2002 | EP1199081A1 Use of inhibition of a growth arrest-specific gene (gas6) function or of a gas6 receptor for preventing and treating a thromboembolic disease |
| 04/24/2002 | EP1199069A2 Use of an estrogen agonist/antagonist for assessing, improving, or maintaining urogenital health |
| 04/24/2002 | EP1198714A2 Predicting proximity to coke formation |
| 04/24/2002 | EP1198713A2 Detection and identification of bacterial strains |
| 04/24/2002 | EP1198712A2 Method for representing biologically activated inductance-altering particles and device for carrying out the method |
| 04/24/2002 | EP1198711A1 Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor |
| 04/24/2002 | EP1198710A1 Analytical method and apparatus |
| 04/24/2002 | EP1198709A1 Glycosaminoglycan metabolites in diabetes diagnosis and treatment |
| 04/24/2002 | EP1198708A1 Method and device for determining the hardness of products such as fruit |
| 04/24/2002 | EP1198706A1 Method and apparatus for x-ray diffraction analyses |
| 04/24/2002 | EP1198703A1 Photoluminescent semiconductor materials |
| 04/24/2002 | EP1198596A1 Data analysis and display system for ligation-based dna sequencing |
| 04/24/2002 | EP1198595A1 Methods and compositions for detecting pathological events |
| 04/24/2002 | EP1198594A2 Polymerase extension at 3' terminus of pna-dna chimera |
| 04/24/2002 | EP1198593A1 Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 04/24/2002 | EP1198591A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 04/24/2002 | EP1198590A2 Polynucleotide sequencing using a helicase |
| 04/24/2002 | EP1198589A1 Tenascin-c nucleic acid ligands |
| 04/24/2002 | EP1198587A1 Apparatus and method for detecting, quantifying and characterizing microorganisms |
| 04/24/2002 | EP1198586A1 An in vivo library-versus-library selection of optimized protein-protein interactions |
| 04/24/2002 | EP1198585A1 Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles |
| 04/24/2002 | EP1198571A2 Chimeric proteins |
| 04/24/2002 | EP1198569A1 G-protein coupled receptor and dna sequences thereof |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198566A2 Method for high-throughput selection of interacting molecules |
| 04/24/2002 | EP1198565A1 A method for preparing modified polypeptides |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198561A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection |
| 04/24/2002 | EP1198554A2 Detection of micro-organisms |
| 04/24/2002 | EP1198480A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 04/24/2002 | EP1198477A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 04/24/2002 | EP1198452A2 System and method for carbohydrate sequence presentation, comparison and analysis |
| 04/24/2002 | EP1198298A1 System for control of blood processor |
| 04/24/2002 | EP1198293A2 Two-part microplate comprising thin-well insert and related fabrication method |
| 04/24/2002 | EP1198255A1 Identification of compounds that modify transcriptional responses to hypoxia |
| 04/24/2002 | EP1198254A2 Carrier-drug conjugate |
| 04/24/2002 | EP1198250A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 04/24/2002 | EP1198245A2 Use of purified invaplex from gram negative bacteria as a vaccine |
| 04/24/2002 | EP1198238A2 Gene encoding nade, p75ntr -associated cell death executor and uses thereof |
| 04/24/2002 | EP1198198A2 Gas analyzer calibration checking device |
| 04/24/2002 | EP1198169A1 A process of cell reprogramming through production of a heterokaryon |
| 04/24/2002 | EP1035921B1 Analytic test element with a capillary canal |
| 04/24/2002 | EP0856155B1 Fluorescent and luminescent labelling compositions and methods for their use |
| 04/24/2002 | EP0851768B1 Interactive molecular conjugates |